findmyKOL
Clinical trialNCT02636387TerminatedObservational

Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

SponsorMontefiore Medical CenterEnrollment14Anemia, Sickle CellNocturnal Enuresis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Hospital at Montefiore

    The Bronx, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Aug 2015
Primary completion
27 Oct 2018
Completion
27 Oct 2018
Last update posted
31 May 2022
Registered enrollment
14
Registry id
NCT02636387

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.